Relay Therapeutics Inc (RLAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 0 | 0 | 0 | 10,007 | -1 |
| Gross Profit | N/A | N/A | N/A | 10,007 | -1 |
| Operating Expenses | 84,979 | 96,369 | 100,757 | 100,370 | 92,195 |
| Operating Income | -84,979 | -96,369 | -100,757 | -90,363 | -92,196 |
| Other Income | 8,975 | 8,264 | 8,545 | 8,976 | 8,701 |
| Pre-tax Income | -76,004 | -88,105 | -92,212 | -81,387 | -83,495 |
| Net Income Continuous | -76,004 | -88,105 | -92,212 | -81,387 | -83,495 |
| Net Income | $-76,004 | $-88,105 | $-92,212 | $-81,387 | $-83,495 |
| EPS Basic Total Ops | -0.42 | -0.63 | -0.69 | -0.62 | -0.66 |
| EPS Basic Continuous Ops | -0.42 | -0.63 | -0.69 | -0.62 | -0.67 |
| EPS Diluted Total Ops | -0.42 | -0.63 | -0.69 | -0.62 | -0.66 |
| EPS Diluted Continuous Ops | -0.42 | -0.63 | -0.69 | -0.62 | -0.67 |
| EPS Diluted Before Non-Recurring Items | -0.45 | -0.63 | -0.69 | -0.62 | N/A |
| EBITDA(a) | $-85,826 | $-98,180 | $-102,680 | $-92,633 | $-94,490 |